Viking Therapeutics, Inc. (VKTX)
29.94
-0.57
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
30.00
+0.06
(+0.20%)
After-Hours: 20:00
Viking Therapeutics Market Cap : 3.493B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.493B |
| October 01, 2026 | 3.559B |
| September 30, 2026 | 3.803B |
| September 29, 2026 | 3.711B |
| September 28, 2026 | 3.853B |
| September 25, 2026 | 4.148B |
| September 24, 2026 | 4.287B |
| September 23, 2026 | 4.859B |
| September 22, 2026 | 4.765B |
| September 21, 2026 | 3.512B |
| September 18, 2026 | 3.382B |
| September 17, 2026 | 3.425B |
| September 16, 2026 | 3.444B |
| September 15, 2026 | 3.494B |
| September 14, 2026 | 3.678B |
| September 11, 2026 | 3.731B |
| September 10, 2026 | 3.748B |
| September 09, 2026 | 3.815B |
| September 08, 2026 | 3.929B |
| September 04, 2026 | 4.068B |
| September 03, 2026 | 3.964B |
| September 02, 2026 | 3.908B |
| September 01, 2026 | 3.928B |
| August 31, 2026 | 3.824B |
| August 28, 2026 | 3.752B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.950B |
| August 26, 2026 | 4.011B |
| August 25, 2026 | 3.986B |
| August 24, 2026 | 3.876B |
| August 21, 2026 | 3.953B |
| August 20, 2026 | 4.008B |
| August 19, 2026 | 4.197B |
| August 18, 2026 | 3.893B |
| August 17, 2026 | 3.923B |
| August 14, 2026 | 3.872B |
| August 13, 2026 | 3.843B |
| August 12, 2026 | 3.969B |
| August 11, 2026 | 3.943B |
| August 10, 2026 | 4.018B |
| August 07, 2026 | 3.997B |
| August 06, 2026 | 3.885B |
| August 05, 2026 | 3.909B |
| August 04, 2026 | 3.843B |
| August 03, 2026 | 3.804B |
| July 31, 2026 | 3.703B |
| July 30, 2026 | 3.862B |
| July 29, 2026 | 3.900B |
| July 28, 2026 | 3.950B |
| July 27, 2026 | 4.068B |
| July 24, 2026 | 4.032B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Eli Lilly & Co. | 1.076T |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
| Amgen, Inc. | 217.88B |
| Ironwood Pharmaceuticals, Inc. | 601.47M |
Market Cap Related Metrics
| PEG Ratio | -0.0315 |
| Price to Book Value | 8.554 |
| Price | 29.94 |
| Earnings Yield | -15.57% |
| PEGY Ratio | -0.0315 |